Interestingly, when we analyzed the expression of macrophage chemotactic cytokines produced by tumor cells in the xenograft model, we observed a significant increase in human GM‐CSF and human TNFα levels after PLX4720 exposure independently from bevacizumab treatment (Appendix Fig S5A). The gene discussed is CSF2; the disease is neoplasm.